LCC
IDXG

Lincoln Capital Corp’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Lincoln Capital Corp’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,035
Closed -$9K – 57
2018
Q1 		$9K Buy
1,035
+35
+4% +$304 0.01% 51
2017
Q4 		$10K Buy
+1,000
New +$10K 0.01% 50